Impact of p16, p53, smoking, and alcohol on survival in patients with oropharyngeal squamous cell carcinoma treated with primary intensity-modulated chemoradiation

被引:33
作者
Broglie, Martina A. [1 ]
Soltermann, Alex [2 ]
Rohrbach, David [2 ]
Haile, Sarah R. [3 ]
Pawlita, Michael [4 ]
Studer, Gabriela [5 ]
Huber, Gerard F. [6 ]
Moch, Holger [2 ]
Stoeckli, Sandro J. [1 ]
机构
[1] Kantonsspital St Gallen, Dept Otorhinolaryngol Head & Neck Surg, CH-9007 St Gallen, Switzerland
[2] Univ Zurich Hosp, Inst Surg Pathol, Zurich, Switzerland
[3] Kantonsspital St Gallen, Clin Trials Unit, CH-9007 St Gallen, Switzerland
[4] German Canc Res Ctr, Res Program Infect & Canc, Dept Genome Modificat & Carcinogenesis, Heidelberg, Germany
[5] Univ Zurich Hosp, Dept Radiat Oncol, Zurich, Switzerland
[6] Univ Zurich Hosp, Dept Otorhinolaryngol Head & Neck Surg, Zurich, Switzerland
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2013年 / 35卷 / 12期
关键词
oropharyngeal squamous cell carcinoma; outcome; survival; HPV; p16; smoking; alcohol; p53; intensity modulated radiotherapy; risk stratification; GROWTH-FACTOR RECEPTOR; HUMAN-PAPILLOMAVIRUS; NECK-CANCER; RADIATION-THERAPY; TONSILLAR CARCINOMAS; HEAD; RADIOTHERAPY; EXPRESSION; PROGNOSIS; RISK;
D O I
10.1002/hed.23231
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
BackgroundAnalysis of the impact of risk factors on survival in patients with oropharyngeal squamous cell carcinoma (OPSCC) treated by primary intensity-modulated radiotherapy (IMRT). MethodsOne hundred forty patients were included with tissue microarray (TMA) construction and immunohistochemical analysis in 124 patients (87%). ResultsSurvival analysis of patients classified into 3 risk categories according to an algorithm based on p16, smoking, T classification, and N classification revealed significant differences with a low, intermediate, and high-risk group. There was a significant impact of p53 expression as surrogate marker for smoking on outcome. In multivariate analysis, p16-positivity was a positive predictor and alcohol as well as N classification was a negative predictor for survival. The algorithm was modified based on alcohol instead of smoking with even more significant differences between the groups. ConclusionsA risk model based on multiple factors instead of p16 as single marker can define different risk groups to select patients for treatment deintensification in future prospective clinical trials. (c) 2013 Wiley Periodicals, Inc. Head Neck 35: 1698-1706, 2013
引用
收藏
页码:1698 / 1706
页数:9
相关论文
共 43 条
[21]   EGFR, p16, HPV titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer [J].
Kumar, Bhavna ;
Cordell, Kitrina G. ;
Lee, Julia S. ;
Worden, Francis P. ;
Prince, Mark E. ;
Tran, Huong H. ;
Wolf, Gregory T. ;
Urba, Susan G. ;
Chepeha, Douglas B. ;
Teknos, Theodoros N. ;
Eisbruch, Avraham ;
Tsien, Christina I. ;
Taylor, Jeremy M. G. ;
D'Silva, Nisha J. ;
Yang, Kun ;
Kurnit, David M. ;
Bauer, Joshua A. ;
Bradford, Carol R. ;
Carey, Thomas E. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (19) :3128-3137
[22]  
Lindel K, 2001, CANCER-AM CANCER SOC, V92, P805, DOI 10.1002/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO
[23]  
2-9
[24]   Tobacco Use in Human Papillomavirus-Positive Advanced Oropharynx Cancer Patients Related to Increased Risk of Distant Metastases and Tumor Recurrence [J].
Maxwell, Jessica H. ;
Kumar, Bhavna ;
Feng, Felix Y. ;
Worden, Francis P. ;
Lee, Julia S. ;
Eisbruch, Avraham ;
Wolf, Gregory T. ;
Prince, Mark E. ;
Moyer, Jeffrey S. ;
Teknos, Theodoros N. ;
Chepeha, Douglas B. ;
McHugh, Jonathan B. ;
Urba, Susan G. ;
Stoerker, Jay ;
Walline, Heather M. ;
Kurnit, David M. ;
Cordell, Kitrina G. ;
Davis, Samantha J. ;
Ward, Preston D. ;
Bradford, Carol R. ;
Carey, Thomas E. .
CLINICAL CANCER RESEARCH, 2010, 16 (04) :1226-1235
[25]   Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer [J].
Mellin, H ;
Dahlgren, L ;
Munck-Wikland, E ;
Lindholm, J ;
Rabbani, H ;
Kalantari, M ;
Dalianis, T .
INTERNATIONAL JOURNAL OF CANCER, 2002, 102 (02) :152-158
[26]   Intensity-Modulated Radiotherapy for Oropharyngeal Squamous Cell Carcinoma [J].
Mendenhall, William M. ;
Amdur, Robert J. ;
Morris, Christopher G. ;
Kirwan, Jessica M. ;
Li, Jonathan G. .
LARYNGOSCOPE, 2010, 120 (11) :2218-2222
[27]   Intensity-modulated radiotherapy in the standard management of head and neck cancer: Promises and pitfalls [J].
Mendenhall, William M. ;
Amdur, Robert J. ;
Palta, Jatinder R. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (17) :2618-2623
[28]   Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. [J].
Mork, J ;
Lie, AK ;
Glattre, E ;
Clark, S ;
Hallmans, G ;
Jellum, E ;
Koskela, P ;
Moller, B ;
Pukkala, E ;
Schiller, JT ;
Youngman, L ;
Lehtinen, M ;
Dillner, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (15) :1125-1131
[29]   Standard chemoradiation versus intensity-modulated chemoradiation: a quality of life assessment in oropharyngeal cancer patients [J].
Mowry, Sarah E. ;
Tang, Christopher ;
Sadeghi, Ahmad ;
Wang, Marilene B. .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2010, 267 (07) :1111-1116
[30]   Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis [J].
Psyrri, A ;
Yu, ZW ;
Weinberger, PM ;
Sasaki, C ;
Haffty, B ;
Camp, R ;
Rimm, D ;
Burtness, BA .
CLINICAL CANCER RESEARCH, 2005, 11 (16) :5856-5862